Gut bacteria may play a role in the rise in colon cancer in young adults
11 hours ago
- #gut-bacteria
- #early-onset-cancer
- #colon-cancer
- Colibactin, a toxin produced by certain E. coli strains and other bacteria, is strongly linked to early-onset colon cancer in younger patients.
- Mutations indicative of past colibactin exposure were found in the majority of colorectal cancer patients analyzed, with younger patients (under 40) showing 3-5 times higher prevalence than older ones.
- Exposure to colibactin likely occurs in early childhood (within the first 10 years of life), potentially accelerating cancer development by 20-30 years.
- The toxin acts as a 'genotoxin,' damaging DNA in gut cells, though it is not ongoing at diagnosis and does not directly prove causation.
- Environmental factors like diet, sedentary lifestyle, medication, and inflammation may trigger colibactin-producing bacteria, influencing cancer risk.
- Colibactin-related mutations are more common in industrialized regions (e.g., U.S., Western Europe) compared to rural, non-industrialized areas.
- Potential influences include birth mode (C-section vs. vaginal), breastfeeding, antibiotic use, and nutrition (e.g., ultra-processed foods), all affecting the gut microbiome.
- While colibactin is a significant 'hit,' it is part of a complex interplay of factors driving colorectal cancer, not a sole cause.
- Future research aims to identify microbial biomarkers for risk assessment and develop targeted drugs against toxins like colibactin, with caution due to ecological impacts.